Maureen M. Goodenow
- Virology top 0.2%
- HIV Research and Treatment 85
- Infectious Diseases top 0.5%
- HIV/AIDS drug development and treatment 40
- HIV/AIDS Research and Interventions 39
- Aging top 2%
- Immunology top 2%
- Immune Cell Function and Interaction 23
- T-cell and B-cell Immunology 10
- Emergency Medicine top 2%
- HIV-related health complications and treatments 8
-
- Cytomegalovirus and herpesvirus research 10
-
- RNA Research and Splicing 6
- Co-authors
- John W. SleasmanDaniel L. TuttleBen M. DunnMarco SalemiThierry HuetWilliam SaurinSimon Wain–HobsonSimon C.M. Kwok
- Cited by
- VirologyInfectious DiseasesAging
- Journals
- AIDS Research and Human Retroviruses (9 papers)Journal of Virology (9 papers)Journal of Leukocyte Biology (8 papers)
- Partner nations
- United StatesFranceUnited Kingdom
In The Last Decade
Maureen M. Goodenow
116 papers receiving 3.9k citations
Peers
Comparison fields: 5 of 126
- Virology 2.4k
- Infectious Diseases 1.8k
- Aging 90
- Immunology 991
- Emergency Medicine 327
Countries citing papers authored by Maureen M. Goodenow
This map shows the geographic impact of Maureen M. Goodenow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maureen M. Goodenow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maureen M. Goodenow more than expected).
Fields of papers citing papers by Maureen M. Goodenow
This network shows the impact of papers produced by Maureen M. Goodenow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maureen M. Goodenow. The network helps show where Maureen M. Goodenow may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Maureen M. Goodenow, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2023 | 2 | |
| 3 | 2017 | 16 | |
| 4 | 2016 | 1 | |
| 5 | 2012 | 5 | |
| 6 | 2012 | 23 | |
| 7 | 2011 | 6 | |
| 8 | 2011 | 19 | |
| 9 | 2011 | 19 | |
| 10 | 2008 | 17 | |
| 11 | 2008 | 16 | |
| 12 | 2008 | 78 | |
| 13 | 2003 | 24 | |
| 14 | 2002 | 63 | |
| 15 | 2000 | 106 | |
| 16 | 2000 | 8 | |
| 17 | 1992 | 18 | |
| 18 | 1990 | 47 | |
| 19 | 1980 | 19 | |
| 20 | Methionine requirement and replacement by homocysteine in tissue cultures of selected rodent and human malignant and normal cells. | 1978 | 69 |
About Maureen M. Goodenow
Maureen M. Goodenow is a scholar working on Virology, Infectious Diseases, Immunology, Emergency Medicine and Microbiology, having authored 118 papers that have together received 4.0k indexed citations. Recurring topics across this work include HIV Research and Treatment (85 papers), HIV/AIDS drug development and treatment (40 papers), HIV/AIDS Research and Interventions (39 papers), Immune Cell Function and Interaction (23 papers), Cytomegalovirus and herpesvirus research (10 papers), T-cell and B-cell Immunology (10 papers), HIV-related health complications and treatments (8 papers) and RNA Research and Splicing (6 papers). The work is most often cited by research in Virology (2.4k citations), Infectious Diseases (1.8k citations), Aging (90 citations), Immunology (991 citations) and Emergency Medicine (327 citations). Maureen M. Goodenow has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include John W. Sleasman, Daniel L. Tuttle, Ben M. Dunn, Marco Salemi, Thierry Huet, William Saurin, Simon Wain–Hobson, Simon C.M. Kwok, John J. Sninsky and Jeffrey K. Harrison. Their work appears in journals such as AIDS Research and Human Retroviruses, Journal of Virology, Journal of Leukocyte Biology, AIDS and Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.